CD34 and acute myeloid leukemia: In this study we detected LSCs (CD34+CD38-) in the undifferentiated AML cell line KG-1a and revealed that they represent approximately 70% of the cell population, whereas in other AML cell lines they are less than 1% and in AML patients around 0.01% to 0.09% [11,28].